GoodRx Holdings (GDRX) FCF Margin (2019 - 2026)

GoodRx Holdings has disclosed FCF Margin across 8 years of filings, most recently posting 4.47% for Q1 2026.

• FCF Margin for Q1 2026 came in at 4.47%, up 160.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 12.83% (down 324.0% YoY), and the FY2025 annual result was 12.22%, down 1083.0% from the prior year.
• FCF Margin came in at 4.47% for Q1 2026 at GoodRx Holdings, down from 9.39% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 44.28% in Q3 2024 to a low of 6.07% in Q1 2025.
• The 5-year median for FCF Margin is 17.23% (2022), against an average of 15.17%.
• Peak annual rise in FCF Margin reached 3015 bps in 2025, while the deepest fall reached 3375 bps in 2025.
• GoodRx Holdings' FCF Margin stood at 17.23% in 2022, then slumped by 90 bps to 1.73% in 2023, then soared by 1196 bps to 22.45% in 2024, then slumped by 58 bps to 9.39% in 2025, then slumped by 148 bps to 4.47% in 2026.
• The last three FCF Margin figures came in at 4.47% (Q1 2026), 9.39% (Q4 2025), and 10.53% (Q3 2025), per Business Quant data.